Supplementary Data from Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in &lt;i&gt;KRAS&lt;/i&gt;-Mutant Non–Small Cell Lung Cancer